Evidence map›Paper›PMID 40104042›Full record

ArticleAsia-Pacific journal of oncology nursing2025

Correlation between cancer cachexia and psychosocial impact in older patients with advanced lung cancer undergoing chemotherapy.

Rika Sato, Tateaki Naito, Haruyasu Murakami, Shota Omori, Haruki Kobayashi, Akira Ono, Nobuaki Mamesaya, Kazushige Wakuda, Ryo Ko, Hirotsugu Kenmotsu and 5 more

Abstract read
In one paragraph

Article in Asia-Pacific journal of oncology nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rika SatoDivision of Nursing, Shizuoka Cancer Center, Shizuoka, Japan.
Tateaki NaitoGraduate School of Nursing Science, St. Luke's International University, Tokyo, Japan.
Haruyasu MurakamiDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Shota OmoriDepartment of Respiratory Medicine and Infectious Disease, Oita University Faculty of Medicine, Oita, Japan.
Haruki KobayashiDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Akira OnoDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Nobuaki MamesayaDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Kazushige WakudaDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Ryo KoDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Hirotsugu KenmotsuDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Sakiko AsoDivision of Nursing, Shizuoka Cancer Center, Shizuoka, Japan.
Miho HasabaDivision of Palliative Medicine, Shizuoka Cancer Center, Shizuoka, Japan.
Keita MoriDivision of Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan.
Toshiaki TakahashiDivision of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
Naoko HayashiGraduate School of Nursing Science, St. Luke's International University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to evaluate the association of cancer cachexia with psychosocial impact, nutrition impact symptoms (NIS), and geriatric assessment in older patients newly diagnosed with advanced lung cancer undergoing chemotherapy. Methods: Older patients with advanced lung cancer scheduled to receive first-line chemotherapy between August 2021 and February 2022 were enrolled. Cachexia was diagnosed according to the International Consensus. NIS and psychosocial impacts were assessed using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires (EORTC QLQ) C30, CAX24, and the Eating-Related Distress Questionnaire (ERD). Non-parametric tests evaluated the association between cachexia and its impacts. Patients with cachexia who consented to be interviewed were asked about their experiences with diet and weight changes. Three authors reviewed the interview data to ensure the analysis's veracity. Results: Twenty-one of the 31 participants (68%) had cachexia at baseline. The cachexia group showed significantly greater severity of Food Aversion ( Conclusions: Cancer cachexia showed an association with NIS and psychosocial impacts. Older patients with advanced lung cancer scheduled to receive first-line chemotherapy should undergo a comprehensive assessment of cancer cachexia, including its potential physical and psychological impacts. Trial registration: The trial registration number was UMIN 000053843.

Indexed as

Cancer cachexiaEating-related distressGeriatric assessmentsNutrition impact symptomsOncology nursingProspective longitudinal study

Identifiers

PMID40104042
PMCPMC11919327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.